<SEC-DOCUMENT>9999999997-23-003177-index.html : 20230810
<SEC-HEADER>9999999997-23-003177.hdr.sgml : 20230810
<ACCEPTANCE-DATETIME>20230613103412
ACCESSION NUMBER:		9999999997-23-003177
CONFORMED SUBMISSION TYPE:	SEC STAFF LETTER
CATEGORY:             	REDACTED EXHIBIT
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20230612
ACTION DATE:               	20230612
RECEIVED DATE:           	20230613

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Apogee Therapeutics, LLC
		CENTRAL INDEX KEY:			0001974640
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				880588063
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SEC STAFF LETTER

	BUSINESS ADDRESS:	
		STREET 1:		221 CRESCENT ST.
		STREET 2:		BUILDING 17, SUITE 102B
		CITY:			WALTHAM
		STATE:			MA
		ZIP:			02453
		BUSINESS PHONE:		650-394-5230

	MAIL ADDRESS:	
		STREET 1:		221 CRESCENT ST.
		STREET 2:		BUILDING 17, SUITE 102B
		CITY:			WALTHAM
		STATE:			MA
		ZIP:			02453

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Apogee Therapeutics, LLC
		DATE OF NAME CHANGE:	20230420
</SEC-HEADER>
<DOCUMENT>
<TYPE>REDACTED EXHIBIT
<SEQUENCE>1
<FILENAME>filename1.pdf
<TEXT>
Document 1 - file: filename1.pdf

</DOCUMENT>
</SEC-DOCUMENT>